Previous 10 | Next 10 |
INCLINE VILLAGE, Nev. , Sept. 10, 2020 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) announced that its Board of Directors has approved the separation of LENSAR, Inc. ("LENSAR"), a majority owned subsidiary of PDL, from PDL in the form of a dividend invo...
PDL BioPharma ( PDLI +1.1% ) has closed the sale of its wholly owned subsidiaries Noden Pharma DAC and Noden Pharma USA to Stanley Capital, for the total value consideration of up to $52.83M in cash, $4.58M greater than previously announced. More news on: PDL BioPharma, Inc., Healthc...
INCLINE VILLAGE, Nev. , Sept. 9, 2020 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) announces the closing of the sale of its wholly owned subsidiaries Noden Pharma DAC and Noden Pharma USA (collectively "Noden") to Stanley Capital. The total valu...
INCLINE VILLAGE, Nev. , Aug. 31, 2020 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) announces the signing and closing of a definitive agreement for the sale of three royalty interests for Kybella ® , Zalviso ® , and Coflex ® (collectively...
PDL BioPharma (NASDAQ: PDLI ) offers to purchase its 2.75% of its convertible notes due 2021 and 2024. More news on: PDL BioPharma, Inc., Healthcare stocks news, Read more ...
INCLINE VILLAGE, Nev. , Aug. 28, 2020 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) today announced that holders of its 2.75% Convertible Senior Notes due in December 2021 (the "2021 Notes") and in December 2024 (the "2024 Notes" and together with th...
PDL BioPharma ( PDLI -0.4% ) medical device subsidiary LENSAR has filed a regulatory document with the SEC for a p otential spinoff . The board, currently exploring strategic alternatives, will make a final decision on the potential move in the coming weeks. More news on: PDL BioPharma, ...
INCLINE VILLAGE, Nev. , Aug. 26, 2020 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) announces that its majority owned medical device subsidiary, LENSAR, Inc. ("LENSAR"), has filed a registration statement on Form 10 with the Securities and Exchange Commi...
PDL BioPharma (NASDAQ: PDLI ) +1.9% PM entered into a settlement agreement with related entities of Defined Diagnostics (f/k/a Wellstat Diagnostics) in order to resolve previously reported litigation relating to loans made to the latter by PDL. More news on: PDL BioPha...
INCLINE VILLAGE, Nev. , Aug. 12, 2020 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) announces it has entered into a settlement agreement (the "Settlement Agreement") with related entities of Defined Diagnostics, LLC (f/k/a Wellstat Diagnostics, LLC) ("Wellsta...
News, Short Squeeze, Breakout and More Instantly...
Price matters most to making money in the market. Celebrating 20 years, Stock Traders Daily provides the tools that help you develop investment strategies, and this is a good example. When we couple this with our market based analysis, the probabilities of going with the flow increases, and t...
PDL BioPharma Enters into $51.4 Million Capital Provision Agreement with Epps Investments LLC Regarding PDL's Previously Announced Settlement Agreement with Wellstat RENO, Nev. , Dec. 14, 2020 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDL...
Penny Stocks to Watch Today Finding the best penny stocks to buy seems simple, but it takes time to identify a clear trend. We saw this week, how quickly these can breakout. We’ve also seen how quickly they can break down. So deciding what type of trading strategy you’...